Targeting VEGFR-2 with piperazine bridged Indolin-2-one derivatives As a key mediator of tumor angiogenesis, VEGFR-2 has emerged as a promising therapeutic target for combating cancer. In the present study, a series of…

New paper out!
In this study, we designed and synthesized a new series of piperazine-bridged indolin-2-one derivatives as inhibitors of VEGFR-2. 🧪

www.sciencedirect.com/science/arti...
#CancerResearch #MedicinalChemistry #VEGFR2 #BreastCancer #DrugDiscovery